Aldo-Keto Reductases: Their Function, Structure and Role in Human Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Biochemistry".
Deadline for manuscript submissions: closed (27 March 2024) | Viewed by 1128
Special Issue Editor
Interests: oxidative stress-induced signal transduction mechanisms; pathophysiology of secondary diabetic complications; carcinogenesis; inflammatory complications; therapeutic development of small molecular inhibitors and antioxidants
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is dedicated to articles focused on aldo-keto reductases (AKRs), investigating their functions, structures, and roles in various human diseases. AKRs, a subset of the NADPH-linked oxidoreductases superfamily, encompass enzymes like aldose reductase, aldehyde reductases, hydroxysteroid dehydrogenases, aflatoxin reductases, and other proteins that reduce a diverse variety of carbonyl compounds. The superfamily comprises 16 families including approximately 200 proteins.
Over the past few decades, research has unveiled the significant involvement of aldo-keto reductases in detoxification and xenobiotic metabolism, as well as lipid and carbohydrate metabolism. Moreover, their impact on human diseases, including diabetes, cancer, and various inflammatory and neurological complications, has been substantiated. The quest for therapeutic solutions has led to the development of aldo-keto reductase inhibitors from both natural and synthetic sources. These inhibitors have undergone evaluation in numerous preclinical and clinical studies, revealing their potential for treating various human diseases, notably inflammatory complications and cancer. Nevertheless, additional preclinical and clinical studies are required to gain a comprehensive understanding of the molecular mechanisms through which AKRs mediate these diseases.
We extend an invitation for contributions to this Special Issue encompassing novel structural and computational studies, functional analyses, preclinical and clinical research, and comprehensive reviews on aldo-keto reductases. The focus lies not only on unraveling the intricacies of AKRs but also on developing potent inhibitors of AKRs characterized by high specificity and minimal adverse effects, which are essential for efficient therapeutic implementation.
Dr. Kota V. Ramana
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- aldose reductase
- aldose reductase inhibitors
- cancer
- diabetes
- inflammation
- molecular modeling
